SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023614
Filing Date
2020-11-12
Accepted
2020-11-12 16:05:38
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20200930_10q.htm 10-Q 628368
2 EXHIBIT 31.1 ex_212659.htm EX-31.1 14283
3 EXHIBIT 31.2 ex_212660.htm EX-31.2 14366
4 EXHIBIT 32.1 ex_212661.htm EX-32.1 5346
5 EXHIBIT 32.2 ex_212662.htm EX-32.2 5462
  Complete submission text file 0001437749-20-023614.txt   2928057

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20200930.xml EX-101.INS 468542
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20200930.xsd EX-101.SCH 33891
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20200930_cal.xml EX-101.CAL 25679
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20200930_def.xml EX-101.DEF 217167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20200930_lab.xml EX-101.LAB 204493
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20200930_pre.xml EX-101.PRE 236260
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 201306594
SIC: 2834 Pharmaceutical Preparations